Int. J. Mol. Sci., Volume 22, Issue 4 (February-2 2021) – 726 articles
Cover Story (view full-size image): Despite the existing prevention campaigns, cervical cancer remains a leading cause of cancer-related deaths in women worldwide. Progress in finding adequate treatment solutions has been slow in the last years, especially for the patients with recurrent or metastatic disease. Consensus dictates that immunotherapy for cervical cancer holds great promise but currently does not live up to its full effect. We discuss the potential of PD-1 targeting therapy for cervical cancer, how it opens doors for personalized treatment, and which clinical trials are aiming to further exploit this approach in cervical cancer. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.